{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-001899","form_type":"8-K","ticker":null,"cik":"0001708331","company_name":"Virpax Pharmaceuticals, Inc.","filed_at":"2024-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.298631+00:00","generated_at":"2026-05-29T12:57:52.201268+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Virpax Pharmaceuticals reduces shareholder meeting quorum threshold to 34%","bullets":["Amendment adopted November 27, 2024, lowering quorum from a majority to 34% of voting power.","Change applies to all future shareholder meetings; filed as Exhibit 3.1.","Bylaw modification may ease passage of shareholder proposals and director elections."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-001899","json":"https://secwatch.observer/filing/0001731122-24-001899.json","markdown":"https://secwatch.observer/filing/0001731122-24-001899.md","text":"https://secwatch.observer/filing/0001731122-24-001899.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001899/0001731122-24-001899-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001899/e6175_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T12:57:52.201268+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d5192926d3dee0b8aec63814694944f678a8a3d","claim":"Virpax Pharmaceuticals, Inc.: Reduced the quorum requirement for shareholder meetings from a majority of voting power to 34% of voting power (effective 2024-11-27).","evidence_excerpt":"On November 27, 2024, Virpax Pharmaceuticals, Inc. (the “Company”) amended its Amended and Restated Bylaws (the “Bylaws”) to modify the quorum requirement for shareholder meetings. The amendment reduced the quorum threshold from a majority of the voting power of the Company’s outstanding shares entitled to vote at a meeting to 34% of such voting power.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708331/000173112224001899/0001731122-24-001899-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2024-11-27"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}